Changes in Mannose-Binding Lectin and Collectin Kidney 1 Levels in Sepsis Patients With and Without Disseminated Intravascular Coagulation

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Mineji HayakawaNobutaka Wakamiya

Abstract

In sepsis, systemic coagulation activation frequently causes disseminated intravascular coagulation (DIC), and the uncontrolled activation of the complement system can induce multiple organ dysfunction and poor prognosis. This study aimed to examine the association of DIC with levels of collectin kidney 1 (CL-K1), a novel collectin of the complement system, and mannose-binding lectin (MBL), a classical-type collectin in patients with sepsis. We collected blood samples prospectively from adult patients with sepsis admitted to the intensive care unit (ICU) from day 1 (admission) to day 5. The CL-K1 and MBL levels were measured by enzyme-linked immunosorbent assay, and DIC was diagnosed by using a scoring algorithm. The correlation of CL-K1 and MBL levels with other coagulation markers was analyzed. There were 37 patients with DIC (DIC group) and 15 without DIC (non-DIC group). Compared to the non-DIC group, the DIC group had more severe conditions and higher mortality. During the 5 days after ICU admission, plasma CL-K1 levels were similar between the groups, but plasma MBL levels were significantly lower in the DIC group. Plasma CL-K1 levels were weakly correlated with prothrombin time, activated partial thromboplastin time, and...Continue Reading

References

Nov 1, 1991·European Journal of Immunology·J L PlattF H Bach
Aug 1, 1983·The Journal of Experimental Medicine·M J Polley, R L Nachman
Sep 1, 1983·Journal of Biochemistry·N KawasakiI Yamashina
Jul 31, 1980·Biochemical and Biophysical Research Communications·Y KozutsumiI Yamashina
Mar 8, 2006·Critical Care Medicine·Satoshi GandoUNKNOWN Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group
Dec 21, 2006·Microbiology and Immunology·Hiroyuki KeshiNobutaka Wakamiya
Sep 29, 2009·Thrombosis Research·Hideo WadaUNKNOWN Japanese Society of Thrombosis Hemostasis/DIC subcommittee
Oct 2, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tom SprongMarcel van Deuren
Nov 7, 2009·Critical Care : the Official Journal of the Critical Care Forum·Jin Won HuhYounsuck Koh
Aug 25, 2010·Human Immunology·Cinzia AuritiFabrizio De Benedetti
Sep 7, 2011·Journal of Biochemistry·Takayuki YoshizakiNobutaka Wakamiya
Sep 21, 2011·Thrombosis Research·Marcello Di NisioUNKNOWN Italian Society for Thrombosis and Haemostasis
May 10, 2012·Journal of Biomedicine & Biotechnology·Katsuki OhtaniNobutaka Wakamiya
Feb 6, 2013·Journal of Thrombosis and Haemostasis : JTH·H WadaUNKNOWN The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis
Aug 30, 2013·The New England Journal of Medicine·Derek C Angus, Tom van der Poll
Jan 30, 2014·Journal of Thrombosis and Thrombolysis·Kazue TakahashiNobutaka Wakamiya
Feb 18, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hiroshi OguraUNKNOWN Japanese Association for Acute Medicine Sepsis Registry (JAAMSR) Study Group
Feb 28, 2014·The New England Journal of Medicine·Beverley J Hunt
Apr 25, 2014·Thrombosis Research·Florea LupuK Mark Coggeshall
Jul 6, 2016·Immunobiology·Soren W K HansenNobutaka Wakamiya

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.